sign in sign up
<<
Home , Amgen, Celgene, Daiichi Sankyo, Eisai (company), Medivation

Summary conflict of interest statements BCC 2021

Last name First name Type of affiliation/ financial interest Name of commercial company Aapro Matti Receipt of grants/research supports: , , Genomic Health, Helsinn, , , Merck, Mundipharma, , Rache, Sandoz, Tesaro, Teva, Vifor Receipt of honoraria or consultation fees: Accord Pharmaceuticals, Amgen, Astellas, Bayer HealthCare Pharmaceuticals (Schering), , , BMS, , , Chugai Pharmaceutical Co. Ltd., Clinigen Group, Dr.Reddy's Laboratories, Eisai Co. Ltd., Eli Lilly, Genomic Health (Exact Sciences), GlaxoSmithKline (GSK), Glenmark Pharmaceuticals Limited, Gl Therapeutics, lnc., Helsinn Healthcare SA, Hospira (Pfizer), lpsen, , Johnson & Johnson, Kyowa Kirin Group, Merck, Merck Serono (Merck KGaA), Mundipharma International Limited, Novartis, Pfizer, Pierre Fabre, Rache, Sandoz, , Taiho Pharmaceutical, Tesaro (GSK), Teva Pharmaceutical lndustries Ltd., Vifor Pharma Other support: European Cancer Organisation, SPCC, Cancer Center Genolier Aebi Stephan Receipt of honoraria or consultation fees: Novartis, Roche, Pfizer Other support: Support for CME lectures of the Lucerne Cancer Center: Amgen, Astellas, Bayer, Bristol-Myers Squibb, Debiopharm International SA, Eisai, Ipsen Pharma, Janssen, Merck, MSD, Pfizer, Roche, Sanofi Genzyme, Servier, Takeda André Fabrice Receipt of grants/research supports: Comepensated to the hospital: Roche, AstraZeneca, , Pfizer, Novartis, Lilly Barrios Carlos Receipt of grants/research supports: Abbvie, Amgen, , AstraZeneca, Bristol-Myers Squibb, Celgene, , Lilly, , Merck Serono, Merck Sharp Dohme (MSD), Novartis, Pfizer, Pharma Mar, Roche/ Receipt of honoraria or consultation fees: Boehringer-lngelheim, GSK, Novartis, Pfizer, Roche/Genentech, Eisai, MSD, Astra Zeneca, Bayer, Lilly Bergh Jonas Receipt of grants/research supports: Grant support for clinical studies with payments to Karolinska Inst and/or Karolinska Univ Hospital Other support: Co-author of a Chapter in UpToDate; prognostic and therapy predictive factors in Early Breast cancer, payments to Asklepios Medicin Hb Bonnefoi Herve Receipt of honoraria or consultation fees: Roche Other support: Travel expenses: Roche, Pfizer Bretel Morales Denisse Receipt of grants/research supports: Roche, MSD Brucker Sara Receipt of grants/research supports: Storz, Intuitive Receipt of honoraria or consultation fees: Roche, MSD, Teva, Olympus, Pfizer, Novartis, AstraZeneca Burstein Harald No potential conflict of interest to report Summary conflict of interest statements BCC 2021

Last name First name Type of affiliation/ financial interest Name of commercial company Cameron David Receipt of honoraria or consultation fees: By institution: MERCK Sharp Dohme Ltd., Clovis, Novartis Pharma, (Seattle Genetics), Erytech Pharma Inc, G1 Therapeutics, Eli Lilly & Company, Daiichi Sankyo, Roche Products Ltd., RTI Health Solutions, PRIMA BioMed Ltd., Eisai, Astrazeneca, Pfizer, Synton, Puma, Zymeworks, Celgene, Samsung Bioepsis, European Cancer Organisation, Succint Medical Communications, Oncolytics Biotech (U.S) Inc, Celldex Therapeutics Inc, San Antonio Breast Cancer Consortium, Highfield Communication Cardoso Fatima Receipt of honoraria or consultation fees: Amgen, Astellas/Medivation, AstraZeneca, Celgene, Daiichi­Sankyo, Eisai, GE Oncology, Genentech, GlaxoSmithKline, Macrogenics, Medscape, Merck-Sharp, Merus BV, , Mundipharma, Novartis, Pfizer, Pierre-Fabre, prlME Oncology, Roche, Samsung Bioepis, Sanofi, Seattle Genetics, Teva Carey Lisa Receipt of honoraria or consultation fees: Seattle Genetics, Novartis - Dr. Carey does not have any signatory authority over any UNC account receiving these contracted monies Cescon Dave Receipt of grants/research supports: GlaxoSmithKline, Pfizer, Roche Receipt of honoraria or consultation fees: Agendia, AstraZeneca, Dynamo Therapeutics, Exact Sciences, GlaxoSmithKline, Merck, Novartis, Pfizer, Puma, Roche Other support: Patent (US62/675,228) for methods of treating cancers characterized by a high expression level of spindle and kinetochore associated complex subunit 3 (ska3) gene Chua Boon Receipt of grants/research supports: NanoString: provision of Prosigna kit for Ciruelos Eva Receipt of honoraria or consultation fees: Lilly, Pfizer, Roche, AstraZeneca, Novartis Participation in a company sponsored speaker's bureau: Lilly, Pfizer, Roche Coates Alan No potential conflict of interest to report Colleoni Marco Receipt of honoraria or consultation fees: Novartis Cortes Javier Receipt of honoraria or consultation fees: Roche, Celgene, Cellestia, AstraZeneca, Biothera Pharmaceutical, Merus, Seattle Genetics, Daiichi Sankyo, Erytech, Athenex, Polyphor, Lilly, Servier, Merck, Sharp&Dohme, GSK, Leuko, Bioasis, Clovis Oncology, Boehringer Ingelheim, Novartis, Eisai, Pfizer, Samsung Bioepis Stock shareholder: MedSIR Other support: Research funding to the Institution: Roche, Ariad pharmaceuticals, AstraZeneca, Baxalta GMBH/Servier Affaires, Bayer healthcare, Eisai, F.Hoffman-La Roche, Guardanth health, Merck Sharp&Dohme, Pfizer, Piqur Therapeutics, Puma C, Queen Mary University of London Travel, accommodation, expenses: Roche, Novartis, Eisai, pfizer, Daiichi Sankyo Summary conflict of interest statements BCC 2021

Last name First name Type of affiliation/ financial interest Name of commercial company Curigliano Giuseppe Receipt of honoraria or consultation fees: Roche, Pfizer, Astra Zeneca, Daichii Sankyo, BMS Delaloge Suzette Receipt of grants/research supports: To the institution: Pfizer, Roche, Novartis, Sanofi, Merck, Puma, Lilly, AstraZeneca, Orion, Daiichi Sankyo Denkert Carsten Receipt of grants/research supports: Receipt of honoraria or consultation fees: Novartis, Roche, MSD, Daiichi Sankyo Stock shareholder: Sividon Diagnostics (Myriad) Dubsky Peter Receipt of grants/research supports: Agendia, Cepheid/Danaher, OncoMark, Myriad (all via ABCSG) Receipt of honoraria or consultation fees: Amgen, Pfizer, Rache, Astra Zeneca (all to Hirslanden Klinik St. Anna) Other support: Travel support: Roche Ejlertsen Bent Receipt of grants/research supports: NanoString Technologies, Oncology Venture, Roche, Novartis Fitzal Florian Receipt of grants/research supports: NanoString Technologies, Pfizer, Novartis, Roche Receipt of honoraria or consultation fees: Lilly, Pfizer, Novartis, Roche, AstraZeneca, Bondimed Francis Prudence Others: Travel to lectures overseas: Novartis, Ipsen Galimberti Viviana No potential conflict of interest to report Gamal El Din Mohamed MHebatallah No potential conflict of interest to report Garber Judy Receipt of grants/research supports: Myriad Genetics, Ambry Genetics, Invitae Genetics, AstraZeneca Receipt of honoraria or consultation fees: Helix Genetics Other support: Editorial Services publications; President, Fellows of the AACR Academy; member, Foundation Board of the AACR: American Association for Cancer Research Co-Scientific Director: Breast Cancer Research Foundation Board of Directors: Facing Our Risk of Cancer Empowered Spouse/partner: Consulting: Novartis, GTx Pharmaceuticals, Aleta BioTherapeutics, H3 Biomedicine Inc. / Scientific Advisory Board: Oric Pharmaceuticals, Kronos Bio, Susan G. Komen for the Cure, James P. Wilmot Foundation, Inc, Diane Helis Henry Medical Research Foundation, Adrienne Helis Melvin Medical Research Foundation, Global Biological Standards Institute Giordano Sharon No potential conflict of interest to report Gnant Michael Receipt of honoraria or consultation fees: Amgen, DaiichiSankyo, EliLilly, Medison Pharma, LifeBrain, Nanostring, Novartis, TLC Spouse/partner: An immediate family member is employed by Sandoz Gradishar William Receipt of honoraria or consultation fees: DMC- Seattle genetics, Advisory board- Genentech, immunomedics, astra-zenenca, Daiichi Other support: Sponsored clinical research: Roche, Genentech Summary conflict of interest statements BCC 2021

Last name First name Type of affiliation/ financial interest Name of commercial company Gulluoglu Bahadir Receipt of honoraria or consultation fees: Roche Harbeck Nadia Receipt of honoraria or consultation fees: Astra Zeneca, Daiichi-Sankyo, Lilly, MSO, Novartis, Pierre Fabre, Pfizer, Roche, Seattle Genetics Participation in a company sponsored speaker's bureau: Astra Zeneca, Daiichi-Sankyo, Lilly, MSO, Novartis, Pierre Fabre, Pfizer, Roche, Seattle Genetics Stock shareholder: Minority ownership WSG (West German Study Group) Spouse/partner: Consulting WSG (West German Studay Group) Heil Jörg No potential conflict of interest to report Huang Chiun-Sheng Receipt of grants/research supports: Astra Zeneca, Daiichi Sankyo, Eli Lilly, MSD, Novartis, OBI, Pfizer, Roche Receipt of honoraria or consultation fees: Amgen, Astra Zeneca, Daiichi Sankyo, Eli Lilly, Pfizer, Roche Participation in a company sponsored speaker's bureau: Astra Zeneca, Eli Lilly, Novartis, Pfizer, Roche Other support: Travel expenses: Roche, AstraZeneca Huober Jens Receipt of grants/research supports: Celgene, Novartis, Hexal Receipt of honoraria or consultation fees: Lilly, Novartis, Roche, Pfizer, Hexal, AstraZeneca, MSD, Celgene, Abbvie, Eisai Other support: Travel expenses: Roche, Pfizer, Novartis, Celgene, Daiichi Ilbawi Andre No potential conflict of interest to report Jiang Zefei No potential conflict of interest to report Johnston Steven Receipt of grants/research supports: Funding to Institution: Pfizer, Eli lilly, Puma , AstraZeneca, Novartis, Roche/Genentech Receipt of honoraria or consultation fees: Eli Lilly, AstraZeneca, Puma Biotechnology, Pfizer, Novartis, Eisai, Roche/Genentech King Tari Receipt of honoraria or consultation fees: Genomic Health, Exact Sciences Krop Ian Receipt of grants/research supports: Genentech/Roche; Pfizer; Daiichi-Sankyo; Taiho Oncology Receipt of honoraria or consultation fees: Genentech/Roche; Daiichi-Sankyo; Taiho Oncology; Macrogenics; Novartis; Bristol-Myers Squibb; Merck; Context Therapeutics Lee Eun Sook No potential conflict of interest to report Lin Nancy Receipt of grants/research supports: To institution: Gentech, Merck, Pfizer Receipt of honoraria or consultation fees: Daiichi Sankyo, Puma, Seattle Genetics Other support: Royalties: up to date Summary conflict of interest statements BCC 2021

Last name First name Type of affiliation/ financial interest Name of commercial company Loi Sherene Receipt of grants/research supports: National Breast Cancer Australia, National Health and Medical Research Council Australia, Breast Cancer Research Foundation USA To institution: Novartis, Bristol Meyers Squibb, Merck, Roche-Genentech, Puma Biotechnology ,Pfizer, Eli Lilly and Seattle Genetics Receipt of honoraria or consultation fees: Acted as consultant (paid to her institution) to Aduro Biotech, Novartis, and G1 Therapeutics

Other support: Acted as consultant (not compensated) to Seattle Genetics, Pfizer, Novartis, BMS, Merck, AstraZeneca and Roche-Genentech Loibl Sibylle Receipt of grants/research supports: Abbvie, Amgen; AstraZeneca,Celgene, Cepheid, Daiichi-Sankyo, Immunomedics, Novartis, Pfizer, Rache Receipt of honoraria or consultation fees: Institute: Abbvie, Amgen; AstraZeneca,Celgene, Cepheid, Daiichi-Sankyo, Immunomedics, Novartis, Pfizer, Rache, Seattle Genetics; Lilly; Samsung, Eirgenix; BMS, Puma; Pierre-Fabre; Merck kG; MSD; Medscape personal: Chugai Morrow Monica Receipt of honoraria or consultation fees: Genomic Health Pagani Olivia Participation in a company sponsored speaker's bureau: Roche, Lilly, Novartis, Takeda, Pfizer Partridge Ann Other support: Novartis travel support for one conference Piccart Martine Receipt of grants/research supports: AstraZeneca, Lilly, MSD, Novartis, Pfizer, Radius, Roche-Genentech, Servier, Synthon Receipt of honoraria or consultation fees: AstraZeneca, Camel-IDS, Crescendo Biologics, Debiopharm, G 1 Therapeutics, Genentech, Huya, Immunomedics, Lilly, Menarini, MSD, Novartis, Odonate, Periphagen, Pfizer, Roche, Seattle Genetics Poortmans Philip Receipt of honoraria or consultation fees: Medical advisor of Sordina IORT Technologies spa Prat Alex Receipt of honoraria or consultation fees: Roche, Pfizer, Novartis, Amgen, BMS, Puma and Oncolytics Biotech, MSD, Lilly Other support: Lecture fees: Roche, Pfizer, Novartis, Amgen, BMS and Daiichi Sankyo, Nanostring technologies Contracted research: Novartis, Nanostring, Roche and Boehringer. Clinical trials: Novartis, Roche, Boehringer, Daiichi Sankyo, Pfizer, Lilly and Amgen. Executive boards: Beast International Group (BIG) and SOLTI cooperative group. Patronage committee: SOLTI Foundation and Actitud

Pusic Andrea Other support: Co-developer of the BREAST-Q and received royalties when it is used in for profit, industry- sponsored clinical trials. Summary conflict of interest statements BCC 2021

Last name First name Type of affiliation/ financial interest Name of commercial company Regan Meredith Receipt of grants/research supports: Bayer, BMS Receipt of honoraria or consultation fees: BMS Participation in a company sponsored speaker's bureau: BMS, Tolar Other support: As Director of the IBCSG Statistical and Data Management Center, Dr. Regan oversees clinical trials (and/or provision of drug supply) and/or translational research funded by: Novartis, Pfizer, Ipsen, TerSera, AstraZeneca, Pierre Fabre, Roche, BMS Rubio Isabella Receipt of honoraria or consultation fees: Sirius Medical Rugo Hope Receipt of grants/research supports: Pfizer, Merck, Novartis, Lilly, Genentech, OBI, Odonate, Daiichi, Seattle Genetics, Eisai, Macrogenics, Immunomedics Receipt of honoraria or consultation fees: Limited consulting with Puma and Samsung Other support: Travel expenses: Daiichi, Mylan, Pfizer, Merck, AstraZeneca, Novartis, Macrogenics Rutgers Emiel No potential conflict of interest to report Sedlmayer Felix Receipt of grants/research supports: Intraop Medical Corp.; Receipt of honoraria or consultation fees: Boston Scientific, Janssen Cilag, Astellas Semiglazov Vladimir No potential conflict of interest to report Shao Zhiming No potential conflict of interest to report Spanic Tanja Receipt of honoraria or consultation fees: Roche, Pfizer Tesarova Petra Receipt of honoraria or consultation fees: Roche, Novartis, AstraZeneca, Eli Lilly, Pfizer, Pierre Fabre Participation in a company sponsored speaker's bureau: Eli Lilly, Novartis, Roche Thürlimann Beat Receipt of honoraria or consultation fees: Amgen, AstraZeneca, Eli Lilly, MSD, Novartis, Pfizer, Roche, Daiichi-Sankyo Stock shareholder: Novartis, Roche Tjulandin Sergei Receipt of grants/research supports: AstraZeneca, Servier, Pierre Fabre Receipt of honoraria or consultation fees: Roche, Novartis, Eli Lilly, Biocad Participation in a company sponsored speaker's bureau: AstraZeneca, MSD, Novartis, Eli Lilly, Pierre Fabre Stock shareholder: RusPharmaTech (Russia) Summary conflict of interest statements BCC 2021

Last name First name Type of affiliation/ financial interest Name of commercial company Toi Masakazu Receipt of grants/research supports: Chugai, Takeda, Pfizer, Kyowa-Kirin, Taiho, Eisai, Shimadzu, Yakult, Nippon-Kayaku, AstraZeneca, Daiichi- Sankyo, JBCRG association, Astellas, AFI technology, Luxonus, , Kansai Medical Net, GL Science Receipt of honoraria or consultation fees: Chugai, Takeda, Pfizer, Kyowa-Kirin, Taiho, Eisai, Shimadzu, Yakult, Nippon-Kayaku, AstraZeneca, Daiichi-Sankyo, Eli-Lilly, Exact Science, Novartis, Konica-Minolta, BMS, Bertis, , Athenex Oncology Participation in a company sponsored speaker's bureau: Eli Lilly, Pfizer, Daiichi-Sankyo Trudeau Maureen Receipt of grants/research supports: Roche, AstraZeneca, Merck, Puma/Knight, Sanofi Stock shareholder: RNA Diagnostics Other support: Co-Author on abstracts related to Neratinib (Puma) Turner Nicholas Receipt of grants/research supports: Astra Zeneca, BiaRad, Pfizer, Rache/Genentech, Clavis, Merck, Sharpe and Dahme, Guardant Health Other support: Advisory board honoraria from Astra Zeneca, Bristol-Myers Squibb, Lilly, Merck Sharpe and Dahme, Novartis, Pfizer, Roche/Genentech, Bicycle Therapeutics, Taiho, Zena pharmaceuticals, Repare therapeutics Tutt Andrew Receipt of grants/research supports: Astrazeneca- Research costs associated with Olympia, Myriad Genetics -Received research support for TNT trial Receipt of honoraria or consultation fees: Pfizer- Ad Board, Merck Serano- Ad board, Vertex- Ad Board, Artios- Ad Board, Inbiomotion- Ad Board, Astrazeneca- Scientific panel Stock shareholder: Inbiomotion – stock option Vaz Luis Inez Receipt of honoraria or consultation fees: Kephren, Amgen, Novartis, AstraZeneca Viale Giuseppe Receipt of grants/research supports: Roche/GenenRoche/Genentech; Ventana Medical Systems;Dako/Asilent Technologies; Cepheid Receipt of honoraria or consultation fees: MSD Oncology; Pfizer; Dal<0; Roche/Genentech; Astellas Pharma; Novartis;Bayer; Daiichi Sankyo Participation in a company sponsored speaker's bureau: Roche/Genentech Watanabe Toru No potential conflict of interest to report Weber Walter Receipt of grants/research supports: Takeda Pharmaceuticals International via Swiss Group for Clinical Cancer Research (SAKK) Receipt of honoraria or consultation fees: Genomic Health, Inc., USA Other support: Institution received funding for conferences and meetings from Sandoz, Genomic Health, Medtronic, Novartis Oncology, Pfizer and Eli Lilly. Summary conflict of interest statements BCC 2021

Last name First name Type of affiliation/ financial interest Name of commercial company Winer Eric P. Receipt of grants/research supports: Roche/Genentech Receipt of honoraria or consultation fees: Carrick Therapeutics, G1 Therapeutics, Genentech/Roche, Genomic Healht, GSK, Jounce, Leap, Lilly, Novartis, Seattle Genentics Xu Binghe Receipt of honoraria or consultation fees: Novartis, Roche, AstraZeneca Participation in a company sponsored speaker's bureau: AstraZeneca, Pfizer, Roche, Eisai